Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.51 - $7.56 $1.35 Million - $20.1 Million
2,652,134 Added 91.17%
5,561,236 $2.48 Million
Q2 2022

Aug 12, 2022

BUY
$0.43 - $1.24 $1.25 Million - $3.61 Million
2,909,102 New
2,909,102 $1.79 Million

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $53.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.